#=========================================================
# Script: 14_interpretation.R
# Author: Vaishnavi Mangam
# Project: TCGA-LUAD-lncRNA-Analysis
#
# Description:
# Biological interpretation of the TCGA-LUAD analysis.
# This script summarizes the major findings and serves
# as the basis for manuscript preparation.
#=========================================================

#---------------------------------------------------------
# Overall Project Summary
#---------------------------------------------------------

# TCGA-LUAD RNA-seq count data were downloaded from the
# Genomic Data Commons (GDC) portal.

# Differential expression analysis was performed using
# DESeq2.

# Long non-coding RNAs (lncRNAs) were extracted from the
# annotated differentially expressed genes.

# WGCNA identified several co-expression modules, with
# the Blue module showing strong biological relevance.

# Hub lncRNAs from the Blue module were prioritized for
# downstream investigation.

# AC135012.3 was selected as the final candidate based
# on differential expression, module membership and
# biological relevance.

#---------------------------------------------------------
# AC135012.3 Findings
#---------------------------------------------------------

# AC135012.3 is significantly downregulated in
# TCGA-LUAD tumor samples.

# Correlation analysis demonstrated strong positive
# association with endothelial-related genes.

# Co-expression network analysis suggested that
# AC135012.3 may participate in vascular and endothelial
# biological processes.

# GO Biological Process enrichment indicated enrichment
# of angiogenesis and vascular development pathways.

# KEGG pathway enrichment suggested involvement in
# signaling pathways associated with tumor progression.

#---------------------------------------------------------
# Survival Analysis
#---------------------------------------------------------

# Kaplan-Meier survival analysis demonstrated significant
# survival separation between high and low AC135012.3
# expression groups.

# Patients with higher AC135012.3 expression exhibited
# improved overall survival.

#---------------------------------------------------------
# Cox Regression
#---------------------------------------------------------

# Univariate Cox proportional hazards regression did not
# demonstrate statistically significant continuous
# expression-associated risk.

# Therefore, AC135012.3 may have prognostic potential,
# but additional validation in independent cohorts is
# required.

#---------------------------------------------------------
# External Validation
#---------------------------------------------------------

# GEPIA2 analysis confirmed reduced AC135012.3 expression
# in LUAD tumor tissue.

# GEPIA2 survival analysis supported the Kaplan-Meier
# findings obtained from TCGA.

# Positive correlations with endothelial-associated
# genes further support the potential biological role of
# AC135012.3.

#---------------------------------------------------------
# Overall Conclusion
#---------------------------------------------------------

# AC135012.3 represents a promising candidate lncRNA
# associated with LUAD progression and patient prognosis.

# Further experimental validation using qRT-PCR,
# functional assays and independent clinical cohorts is
# recommended to confirm its biological role.
